Physical Activity for Alzheimer's Disease
(RAATE-MCI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how physical activity affects risk factors for Alzheimer's Disease, specifically in older African American adults. Participants will join either a physical activity program or a group focused on low-intensity activities and healthy aging education. Ideal candidates are African American, 60 or older, physically able to exercise, and not currently active. The study will last 52 weeks and aims to provide insights into how staying active might aid in Alzheimer's prevention. As an unphased trial, this study offers a unique opportunity to contribute to important research on Alzheimer's prevention within the community.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that physical activity is safe and beneficial for brain health, particularly in older adults. Studies have found that regular exercise can enhance thinking, learning, and memory.
In some studies, individuals who exercised regularly had a lower risk of memory problems related to Alzheimer's disease, suggesting that physical activity might slow or delay memory issues.
Additionally, these studies report that participants generally express satisfaction with the exercise programs and maintain them for a year with few problems. This indicates that the exercises are easy to follow and do not cause major issues.
For those in the successful aging program, similar positive results have been observed. Regular physical activity, even simple activities like walking, is linked to maintaining brain health and may reduce the risk of developing Alzheimer's disease over time.
In summary, both programs emphasize physical activity, which appears safe and beneficial for the brain. They are designed to integrate into daily life without causing harm. For those considering joining a trial, these findings suggest that the activities are manageable and well-received by participants.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for Alzheimer's disease because they focus on physical and healthy lifestyle changes, which are different from the usual medication-based approaches like cholinesterase inhibitors or NMDA receptor antagonists. One approach involves a structured program of 150 minutes of physical activity per week, which is believed to potentially improve cognitive function and overall well-being. The other approach combines low-intensity activities with educational components on healthy aging, aiming to enhance quality of life through lifestyle changes. These methods represent a shift towards holistic, non-pharmacological strategies that could offer additional benefits without the side effects associated with drugs.
What evidence suggests that this trial's treatments could be effective for Alzheimer's Disease?
Research has shown that physical activity can benefit people with Alzheimer's. Studies have found that exercise might improve the ability to perform daily tasks and maintain mental stability. Regular exercisers are up to 20% less likely to develop dementia, including Alzheimer's. In this trial, participants will join one of two treatment arms. The Physical Activity arm involves 150 minutes of physical activity weekly, which can enhance thinking skills and quality of life for those with Alzheimer's. The Successful Aging arm includes a low-intensity activity program and a healthy aging educational component. Even light activities can help keep the mind sharp and improve memory and decision-making. Both approaches suggest that regular exercise can slow mental decline.678910
Who Is on the Research Team?
Robert L Newton, Jr., PhD
Principal Investigator
Pennington Biomedical Research
Owen Carmichael, PhD
Principal Investigator
Pennington Biomedical Research
Are You a Good Fit for This Trial?
The RAATE-MCI trial is for African American adults aged 60 or older who self-identify as such, are willing to be randomly assigned to groups, can attend sessions and travel within the study area for a year. They must be physically able to exercise but not currently active, have mild cognitive impairment without severe dementia, and agree to data use after the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to either a physical activity intervention or a successful aging group for 52 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Physical activity program
- Successful Aging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pennington Biomedical Research Center
Lead Sponsor
National Institute on Aging (NIA)
Collaborator